NEW YORK, May 13 (GenomeWeb News) - The National Cancer Institute has awarded 13 grants worth a total of $11 million to fund research for the next five years under its Early Detection Research Network, the agency said yesterday.
Four of the grants go to institutions not previously funded by EDRN, whose goal is to establish validated biological markers that are ready for large-scale clinical testing. The funding covers three of the network's four components: clinical epidemiology and validation centers, biomarker reference laboratories, and a data management and coordinating center, as well as an informatics center. Funding for the fourth component, biomarker development laboratories, was awarded late last year.
Funding for epidemiology and validation centers goes to the
Biomarkers reference laboratories funding was awarded to the National Institute of Standards and Technology,